We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Controlling Bacteria Without Antibiotics

By Biotechdaily staff writers
Posted on 28 Jun 2005
A method for controlling the activity of bacteria not with the use of antibiotics but by interfering with their communication process has been developed by an Israeli researcher.

Most human and animal diseases are associated with bacteria assembled in communities called biofilms, which attach themselves to the surfaces of live tissues, implants, and teeth. More...
Biofilm can also be found on artificial surfaces such as water pipes and air-conditioning ducts.

Recently, it was discovered that bacteria assembled in biofilms have a network of communication among them called "quorum sensing,” which controls their collective activity or lack of activity. These sensing signals control the physiology and pathogenicity of the bacteria in biofilms. A boron-based molecule produced by these bacteria, called auto inducer-2, controls the signals in this quorum-sensing process.

Dr. Adel Jabbour, of the Hebrew University of Jerusalem (Israel), has succeeded in synthesizing modified chemical compounds, resembling the structure of the natural auto inducer-2, that can disrupt the signaling. By altering the molecular structure in these compounds, Dr. Jabbour was able to show that it is possible to control the quorum sensing responses in order to "deceive” the bacteria. The modified compounds distort the signaling that sets off the bacterial changes, making it possible to seriously hamper the bacterial action, or to enhance it in cases where the bacteria are beneficial.

This control over quorum sensing provides a promising new avenue for the future treatment of bacterial pathogenic activity without having to resort to antibiotic drugs and their accompanying disadvantages. Also, enhancing quorum sensing could prove useful in agriculture, biotechnology, and the food industry, where increasing bacterial activity is sometimes a benefit.

For his work, Dr. Jabbour was presented with a Kaye Innovation Award in June 2005 during the 68th meeting of the Hebrew University Board of Governors.




Related Links:
Hebrew U. of Jerusalem

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.